Health

  • October 15, 2026

    Optum Sued Over 'Junk Fees' For Online COBRA Payments

    Optum Financial on Wednesday was hit with a proposed class action in California federal court alleging it tacks on sham, unavoidable $20 "junk fees" when customers pay online for healthcare benefits administered through COBRA, which they don't know about until checkout. 

  • October 15, 2026

    Trump Admin Urges High Court To Curb APA Rule Vacatur

    The Trump administration is asking the U.S. Supreme Court to decide whether the Administrative Procedure Act allows federal judges to universally vacate agency rules in what could be a major test of the judiciary's authority to check executive agency power.

  • October 15, 2026

    Feds Seek To Undo Colo. Payment To Defunct Health Insurer

    The federal government Wednesday asked a Colorado federal judge to reverse the approved distribution of nearly $2 million in assets from a defunct insurer to its creditors, claiming that a nearly $24 million claim from the U.S. Department of Health and Human Services supersedes the general creditors' claims.

  • October 15, 2026

    OrbiMed Closes 2 Latest Funds With Combined $3B In Tow

    Healthcare-focused investment firm OrbiMed on Thursday revealed that it has secured $3 billion of investor commitments across its two latest private equity funds.

  • October 15, 2026

    Medical AI Platforms Report Settlement Amid Discovery Battle

    Medical artificial intelligence startup OpenEvidence and competitors Doximity Inc. and Pathway Medical Inc. told a Massachusetts federal judge on Thursday that they have reached a settlement in principle to resolve a contentious lawsuit and counterclaim.

  • October 15, 2026

    PhRMA Again Seeks To Join 340B Rebate Pilot Fight

    The Pharmaceutical Research and Manufacturers of America on Thursday asked a Maine federal court to let it join a lawsuit challenging the Trump administration's proposed rebate system in the 340B drug discount program, arguing the litigation could directly affect its members' approved plans and financial interests.

  • October 15, 2026

    Medical Practice Says Coverys Owes Defense In Abuse Suits

    A Massachusetts medical practice that employed a rheumatologist now accused of sexually abusing hundreds of patients is asking a judge to find that insurer Coverys is obligated to defend and indemnify it and several employees for related negligence claims.

  • October 15, 2026

    Calif. Pot Shop Escapes Suit Over Alleged Gummy Reaction

    A California appeals court threw out a man's fraud and unfair competition claims against a cannabis dispensary that sold him a gummy he said induced a panic attack, saying his complaint fails to indicate the dispensary or its employee knowingly misled him.

  • October 14, 2026

    Genentech Wins Judge's OK Of $18M Novartis Award

    A D.C. federal judge has enforced a nearly $18 million arbitral award against Novartis Pharma AG following its dispute with biotechnology firm Genentech Inc. over a licensing agreement for an eye medication.

  • October 14, 2026

    NC Health Plan Can't Block Atrium's Cost-Sharing Program

    Atrium Health can move forward with a program to offer lower healthcare costs to members of North Carolina's state health plan, a state court judge ruled, handing a loss to the state treasurer in his lawsuit claiming Atrium's program will ultimately saddle the plan with more debt.

  • October 14, 2026

    2nd Circ. Skeptical Of Reviving $4.4M 'Multiplex' COVID Suit

    A Second Circuit judge cast doubt Wednesday on a Connecticut medical practice's claim that insurers owe $4.4 million for COVID-19 testing, noting that the tests at issue were actually for nearly two dozen viruses and were vastly more expensive than those that only detected the novel coronavirus.

  • October 14, 2026

    Cannabis Reform Foes Cite GAO In Push To Reopen Hearings

    A U.S. Drug Enforcement Administration administrative law judge on Wednesday ordered the government to respond to a bid by opponents of cannabis reform to reopen hearings on a proposal to loosen federal restrictions on marijuana.

  • October 14, 2026

    Anthropic Seeks To Dodge AI Patent Suit From U. of Tenn.

    Anthropic says it shouldn't have to face a lawsuit accusing it of infringing a pair of patents related to neural networks owned by a research arm of the University of Tennessee because its Claude artificial intelligence tool isn't covered by the patents.

  • October 14, 2026

    Panel Won't Revive Doctor's MedMal Suit Against Emory

    A Georgia appeals court declined Wednesday to reinstate a doctor's lawsuit against Emory Healthcare, ruling that the doctor's bankruptcy proceedings didn't extend the state's five-year deadline for bringing medical malpractice claims.

  • October 14, 2026

    Ex-Prosecutor To Lead Meland Budwick Health Law Practice

    A former federal prosecutor suing U.S. Department of Justice officials over his termination from the DOJ last year will lead Miami-based law firm Meland Budwick PA's new health law practice, the firm announced.

  • October 14, 2026

    Manhattan DA Unveils Corporate Crime & Antitrust Task Force

    Manhattan District Attorney Alvin Bragg on Wednesday announced the formation of a new task force that will focus on prosecuting corporate crime and antitrust violations, as part of a push to deter industrywide misconduct and promote systemic accountability for entities that encourage and enable financial crimes.

  • October 14, 2026

    Fox Rothschild Beats Daycare's Malicious Prosecution Suit

    A New Jersey state court dismissed an adult daycare company's suit against Fox Rothschild LLP and one of its attorneys related to their prosecution of a fraudulent loan lawsuit that led to a $65,000 sanction against the firm, according to a court order.

  • October 14, 2026

    Healthcare CEO Gets 19 Years In $450M Medicare Scheme

    A Florida federal judge sentenced a former healthcare executive Wednesday to 19 years in prison for running a $450 million scheme to swindle Medicare by using software that created false prescriptions for orthotic braces.

  • October 14, 2026

    Genesis Healthcare Gets Approval For Liquidation Plan

    A Texas bankruptcy judge Wednesday approved Genesis Healthcare's Chapter 11 liquidation plan after the nursing home operator secured the final signature it needed to close the $1 billion sale of its facilities.

  • October 14, 2026

    Sanofi Agrees Not To Disparage Rival's Flu Vaccine

    European enforcers have accepted commitments from Sanofi over concerns that it blocked competition from a rival flu vaccine for vulnerable patients by making disparaging statements to healthcare professionals in Germany and France.

  • October 14, 2026

    IRS Proposes To Block Immigrants From Premium Tax Credit

    Rules proposed Wednesday by the Internal Revenue Service would bar many immigrants from claiming the refundable tax credit for health insurance purchased through an exchange and impose new verification requirements for advance payments. 

  • October 14, 2026

    7-Eleven To Pay $2.3M To Resolve Tobacco Fee Fight

    7-Eleven Inc. will pay $2.3 million to settle a proposed class action alleging it violated federal benefits law by failing to let tobacco-using workers who completed a cessation program totally avoid a $720 annual health plan fee, according to a filing in Texas federal court.

  • October 13, 2026

    Liquidia Settles United Therapeutics Suits With $380.7M Deal

    Liquidia will pay out $380.7 million as part of a settlement agreement with United Therapeutics Corp. that resolves six lawsuits between the pharmaceutical companies, Liquidia announced Tuesday, saying patients will continue to have access to its Yutrepia lung disease treatment that was central to litigation.

  • October 13, 2026

    Skadden Adds 5 DLA Piper Mass Torts Attys To Chicago Office

    Skadden Arps Slate Meagher & Flom LLP continues to grow its mass torts and products liability litigation offerings in its Chicago office with the addition of five veteran litigators from DLA Piper, the firm announced on Tuesday.

  • October 13, 2026

    Feds' Mich. SNAP Records Fight Paused Pending Calif. Ruling

    A Michigan federal judge Tuesday paused the Trump administration's lawsuit that seeks to force Michigan into handing over certain Supplemental Nutrition Assistance Program applicant records, saying a California federal court overseeing the same "core legal issue" in a lawsuit filed by Michigan and other states should rule first.

Expert Analysis

  • Illinois Audit Law Will Make AI Clauses Actually Enforceable

    Author Photo

    A law recently enacted in Illinois creates a first-in-the-nation requirement for artificial intelligence developers to undergo annual audits, providing objective standards that can be incorporated into private contracts and addressing the problem of defining responsible AI use, says William Tanenbaum at Moses & Singer.

  • How Justices' TPS Ruling Affects Workforce Planning

    Author Photo

    The U.S. Supreme Court’s recent holding in Mullin v. Doe that courts lack jurisdiction to review temporary protected status determinations greenlights the end of TPS for thousands of Syrian and Haitian nationals, and means employers must reevaluate TPS-designees' employability while avoiding discriminatory document practices, says attorney Richard Herman.

  • A New Regulatory Environment For PE In Calif. Healthcare

    Author Photo

    The California Office of Health Care Affordability's proposed revisions to its cost and market impact review regulations, amid broader state scrutiny of private equity-backed healthcare arrangements, represent a qualitative shift in California's regulatory posture toward institutional healthcare investment, say attorneys at Ropes & Gray.

  • Justices' Ruling Alters Playing Field For State Subpoena Suits

    Author Photo

    The U.S. Supreme Court’s decision in First Choice Women’s Resource Centers v. Davenport will spark more federal court challenges to state subpoenas, but procedural defenses will block some merits decisions, so plaintiffs must carefully time and manage parallel federal and state proceedings, say attorneys at Troutman.

  • FDA Moves Leave Peptides In A Legal Gray Zone

    Author Photo

    While the U.S. Food and Drug Administration has taken a concrete step forward on reclassifying certain peptides, the practical consequence of their interim status cannot be overstated — these substances are no longer designated as posing a significant safety risk, but they have not been affirmatively authorized for compounding, say attorneys at Sheppard.

  • Series

    Bass Fishing Makes Me A Better Lawyer

    Author Photo

    Landing a trophy striped bass and closing a big deal both require cultivating the patience to finesse — not force — your way to desired outcomes, changing course when your old approach isn’t working and learning from the ones that got away, says Jon Ruiss at Alston & Bird.

  • Series

    NY Banking Brief: All The Notable Legal Updates In Q2

    Author Photo

    The year's second quarter brought several notable banking law developments to New York, including a proposal to align state stablecoin rules with the federal Genius Act, fresh fair lending and cybersecurity guidance from state regulators, and a significant Second Circuit holding on preemption, say attorneys at Ashurst Perkins Coie.

  • Roundup

    The Most Talked-About Supreme Court Decisions Of 2026

    Author Photo

    This term, 11 U.S. Supreme Court decisions quickly became hot topics among Law360's guest writers.

  • A New Defense For Medicaid Fraud Cases In Texas

    Author Photo

    The Texas Supreme Court decision in LabCorp v. Texas last month, finding that the state's False Claims Act requires proof that an omission is material, is among the first to establish that the government's lack of reaction to the defendant's disclosures rendered alleged omissions immaterial, say attorneys at Sheppard.

  • Pregnancy Bias Suits Highlight EEOC's Expanding Reach

    Author Photo

    Recent U.S. Equal Employment Opportunity Commission suits show that enactment of the Pregnant Workers Fairness Act has drawn scrutiny to a wider range of employment decisions and an increasing focus on individual decisions as indicators of whether an employer's policies comply with evolving federal requirements, say attorneys at Krevolin Horst.

  • Quantum Readiness May Paradoxically Raise Contractor Risk

    Author Photo

    The organizations best positioned for the cryptographic system migration deadlines and other requirements under President Donald Trump’s recent quantum executive orders will be those able to inventory their cryptographic dependencies while protecting their vulnerability road map from adversaries, says Jesse Lemon at The Beckage Firm.

  • Immigration Ruling Maps Alternative To Universal Injunctions

    Author Photo

    A Rhode Island federal court's decision in Dorcas International Institute of Rhode Island v. USCIS vacating policies that froze key immigration adjudications for nationals of 39 countries, and paused asylum applications altogether, suggests how practitioners might press for the Administrative Procedure Act's bad faith exception to record review and seek vacatur as a viable alternative to universal injunctions, says Kemal Hepsen at Mandamus Lawyers.

  • How Maine's Expanded Health Deal Reviews Complicate M&A

    Author Photo

    A pair of recently approved Maine competition laws establish notice and approval requirements for certain healthcare transactions and expand state antitrust oversight, creating new hurdles for dealmakers as states take a more aggressive role in policing healthcare consolidation, especially involving private equity, say attorneys at McDermott.

  • Wound Care Industry Should Expect Data-Driven Scrutiny

    Author Photo

    The U.S. Department of Justice's recent update on its healthcare fraud takedown efforts indicates that the wound care space is under particularly high scrutiny, with the government increasingly utilizing data analytics to find cases, say attorneys at Bass Berry.

  • Legal Risks Of Using AI To Screen Psychedelic Trial Patients

    Author Photo

    Though using artificial intelligence to preemptively identify drug trial participants likely to experience placebo effects could produce clearer research results, sponsors will need to be ready for the new legal questions these methods raise about informed consent, accountability for algorithmically derived criteria, and potential bias in data training sets, says Kimberly Chew at Husch Blackwell.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.